Cargando…
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
BACKGROUND: Although current chemotherapy regimens have remarkably improved the cure rate of pediatric acute promyelocytic leukemia (APL) over the past decade, more than 20% of patients still die of the disease, and the 5-year cumulative incidence of relapse is 17%. The precise gene pathways that ex...
Autores principales: | Zhang, Hua, Luo, Xue-Qun, Feng, Dan-Dan, Zhang, Xing-Ju, Wu, Jun, Zheng, Yu-Sheng, Chen, Xiao, Xu, Ling, Chen, Yue-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189170/ https://www.ncbi.nlm.nih.gov/pubmed/21880154 http://dx.doi.org/10.1186/1476-4598-10-108 |
Ejemplares similares
-
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
por: Noguera, N. I., et al.
Publicado: (2019) -
From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network
por: Yuan, Ruoshi, et al.
Publicado: (2016) -
NRF2 activation induced by PML‐RARα promotes microRNA 125b‐1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia
por: Yu, Xibao, et al.
Publicado: (2021) -
Upregulation of MicroRNA-125b Leads to the Resistance to Inflammatory Injury in Endothelial Progenitor Cells
por: Yang, Ke, et al.
Publicado: (2020) -
Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)